Developing a woman-controlled contraceptive using antibodies
Project 1: Industrialization of ZB-06
This study is exploring a new type of birth control that women can use themselves, which not only helps prevent pregnancy but also protects against sexually transmitted infections, and right now, they're testing a new film that targets sperm to keep it from fertilizing an egg.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University Medical Campus NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10923981 on NIH RePORTER |
What this research studies
This research focuses on creating an innovative contraceptive method that women can control, utilizing monoclonal antibodies. The project aims to develop a product that not only prevents pregnancy but also offers protection against sexually transmitted diseases. Through previous trials, researchers have tested intravaginal films containing antibodies that neutralize HIV and HSV, showing promising safety and efficacy. The current phase involves testing a new film, ZB-06, which targets sperm to prevent fertilization effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research are women seeking effective contraceptive methods and those interested in protecting themselves from sexually transmitted diseases.
Not a fit: Patients who are not seeking contraception or who have contraindications to using intravaginal products may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide women with a safe and effective contraceptive option that also protects against certain sexually transmitted infections.
How similar studies have performed: Previous research has shown success with similar antibody-based approaches in contraceptive development, indicating a promising avenue for this novel method.
Where this research is happening
Boston, United States
- Boston University Medical Campus — Boston, United States (Active)
Researchers
- Principal investigator: Whaley, Kevin — Boston University Medical Campus
- Study coordinator: Whaley, Kevin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.